| UniProt ID | ST7_HUMAN | |
|---|---|---|
| UniProt AC | Q9NRC1 | |
| Protein Name | Suppressor of tumorigenicity 7 protein | |
| Gene Name | ST7 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 585 | |
| Subcellular Localization |
Membrane Multi-pass membrane protein . |
|
| Protein Description | May act as a tumor suppressor.. | |
| Protein Sequence | MAEAATGFLEQLKSCIVWSWTYLWTVWFFIVLFLVYILRVPLKINDNLSTVSMFLNTLTPKFYVALTGTSSLISGLILIFEWWYFRKYGTSFIEQVSVSHLRPLLGGVDNNSSNNSNSSNGDSDSNRQSVSECKVWRNPLNLFRGAEYNRYTWVTGREPLTYYDMNLSAQDHQTFFTCDSDHLRPADAIMQKAWRERNPQARISAAHEALEINEIRSRVEVPLIASSTIWEIKLLPKCATAYILLAEEEATTIAEAEKLFKQALKAGDGCYRRSQQLQHHGSQYEAQHRRDTNVLVYIKRRLAMCARRLGRTREAVKMMRDLMKEFPLLSMFNIHENLLEALLELQAYADVQAVLAKYDDISLPKSATICYTAALLKARAVSDKFSPEAASRRGLSTAEMNAVEAIHRAVEFNPHVPKYLLEMKSLILPPEHILKRGDSEAIAYAFFHLAHWKRVEGALNLLHCTWEGTFRMIPYPLEKGHLFYPYPICTETADRELLPSFHEVSVYPKKELPFFILFTAGLCSFTAMLALLTHQFPELMGVFAKAMIDIFCSAEFRDWNCKSIFMRVEDELEIPPAPQSQHFQN | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 25 | Phosphorylation | WSWTYLWTVWFFIVL HHHHHHHHHHHHHHH | 12.79 | 26074081 | |
| 36 | Phosphorylation | FIVLFLVYILRVPLK HHHHHHHHHHHCCCC | 9.08 | 26074081 | |
| 47 | N-linked_Glycosylation | VPLKINDNLSTVSMF CCCCCCCCHHHHHHH | 31.25 | UniProtKB CARBOHYD | |
| 49 | Phosphorylation | LKINDNLSTVSMFLN CCCCCCHHHHHHHHH | 32.77 | 22210691 | |
| 50 | Phosphorylation | KINDNLSTVSMFLNT CCCCCHHHHHHHHHH | 21.55 | 22210691 | |
| 52 | Phosphorylation | NDNLSTVSMFLNTLT CCCHHHHHHHHHHCC | 12.14 | 22210691 | |
| 57 | Phosphorylation | TVSMFLNTLTPKFYV HHHHHHHHCCCCEEE | 33.87 | 23663014 | |
| 67 | Phosphorylation | PKFYVALTGTSSLIS CCEEEEHHCCHHHHH | 28.77 | 22210691 | |
| 69 | Phosphorylation | FYVALTGTSSLISGL EEEEHHCCHHHHHHH | 15.20 | 22210691 | |
| 88 | Phosphorylation | EWWYFRKYGTSFIEQ HHHHHHHHCCCHHEE | 22.75 | 27732954 | |
| 90 | Phosphorylation | WYFRKYGTSFIEQVS HHHHHHCCCHHEEEE | 19.85 | 27732954 | |
| 91 | Phosphorylation | YFRKYGTSFIEQVSV HHHHHCCCHHEEEEH | 21.62 | 27732954 | |
| 97 | Phosphorylation | TSFIEQVSVSHLRPL CCHHEEEEHHHHHHC | 20.00 | 27732954 | |
| 99 | Phosphorylation | FIEQVSVSHLRPLLG HHEEEEHHHHHHCCC | 14.86 | 24719451 | |
| 261 | Ubiquitination | AEAEKLFKQALKAGD HHHHHHHHHHHHHCC | 45.13 | - | |
| 265 | Ubiquitination | KLFKQALKAGDGCYR HHHHHHHHHCCCCHH | 54.03 | - | |
| 304 (in isoform 6) | Ubiquitination | - | 1.86 | 21890473 | |
| 311 (in isoform 6) | Ubiquitination | - | 34.89 | 21890473 | |
| 331 (in isoform 5) | Ubiquitination | - | 2.77 | 21890473 | |
| 338 (in isoform 5) | Ubiquitination | - | 4.10 | 21890473 | |
| 345 (in isoform 6) | Ubiquitination | - | 3.40 | 21890473 | |
| 347 (in isoform 3) | Ubiquitination | - | 17.69 | 21890473 | |
| 354 (in isoform 7) | Ubiquitination | - | 2.74 | 21890473 | |
| 354 (in isoform 3) | Ubiquitination | - | 2.74 | 21890473 | |
| 354 (in isoform 2) | Ubiquitination | - | 2.74 | 21890473 | |
| 358 | Phosphorylation | VQAVLAKYDDISLPK HHHHHHHCCCCCCCC | 17.15 | - | |
| 361 (in isoform 7) | Ubiquitination | - | 4.10 | 21890473 | |
| 361 (in isoform 2) | Ubiquitination | - | 4.10 | 21890473 | |
| 362 | Phosphorylation | LAKYDDISLPKSATI HHHCCCCCCCCCHHH | 45.68 | 24719451 | |
| 372 (in isoform 5) | Ubiquitination | - | 10.88 | 21890473 | |
| 377 | Ubiquitination | CYTAALLKARAVSDK HHHHHHHHHHHCCCC | 36.35 | 21890473 | |
| 377 (in isoform 4) | Ubiquitination | - | 36.35 | 21890473 | |
| 377 (in isoform 1) | Ubiquitination | - | 36.35 | 21890473 | |
| 382 | Phosphorylation | LLKARAVSDKFSPEA HHHHHHCCCCCCHHH | 33.81 | 23186163 | |
| 384 (in isoform 1) | Ubiquitination | - | 39.99 | 21890473 | |
| 384 (in isoform 4) | Ubiquitination | - | 39.99 | 21890473 | |
| 384 | Ubiquitination | KARAVSDKFSPEAAS HHHHCCCCCCHHHHH | 39.99 | 21890473 | |
| 386 | Phosphorylation | RAVSDKFSPEAASRR HHCCCCCCHHHHHHC | 27.80 | 10889047 | |
| 388 (in isoform 3) | Ubiquitination | - | 56.52 | 21890473 | |
| 391 | Phosphorylation | KFSPEAASRRGLSTA CCCHHHHHHCCCCHH | 29.56 | 19691289 | |
| 395 (in isoform 2) | Ubiquitination | - | 3.79 | 21890473 | |
| 395 (in isoform 7) | Ubiquitination | - | 3.79 | 21890473 | |
| 396 | Phosphorylation | AASRRGLSTAEMNAV HHHHCCCCHHHHHHH | 28.53 | - | |
| 397 | Phosphorylation | ASRRGLSTAEMNAVE HHHCCCCHHHHHHHH | 31.51 | - | |
| 418 (in isoform 1) | Ubiquitination | - | 47.65 | 21890473 | |
| 418 (in isoform 4) | Ubiquitination | - | 47.65 | 21890473 | |
| 418 | Ubiquitination | EFNPHVPKYLLEMKS HHCCCCCHHHHHHHH | 47.65 | 21890473 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ST7_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ST7_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
Oops, there are no PPI records of ST7_HUMAN !! | ||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-386, AND MASSSPECTROMETRY. | |